Omnicell (OMCL) is an industry leader in medication management for hospitals and healthcare facilities. The company has what Warren Buffett calls a strong "economic moat." The results speak for themselves as Omnicell received record orders in 3Q, of which 35% came from new customers for its automated dispensing systems. Because of its strong "economic moat," shares are up 56% YTD and we see further gains ahead.
Medication management at its best
Omnicell enables healthcare facilities to manage, dispense and administer medications and medical-surgical supplies to enhance patient safety, reduce medication errors, reduce operating costs, and increase operational efficiency. The company serves over 2,700 hospital customers.
Of those customers, over 1,800 have automated dispensing machines...
Only subscribers can access this article, which is part of the PRO research library covering 3,581 different stocks.
Growing numbers of fund managers and other investment professionals subscribe to Seeking Alpha PRO for equity research that is unavailable elsewhere, so they can: